Analysis of the utilization, processes, and outcomes of inpatient mental healthcare during the first three waves of the COVID-19 pandemic in the federal state of North Rhine-Westphalia, Germany.

COVID-19 inpatient mental healthcare pandemic psychiatric services utilization

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2022
Historique:
received: 31 05 2022
accepted: 30 11 2022
entrez: 9 1 2023
pubmed: 10 1 2023
medline: 10 1 2023
Statut: epublish

Résumé

During the first phase of the Coronavirus-19 disorder (COVID-19) pandemic in the spring of 2020, utilization of inpatient mental healthcare was significantly reduced. We now report on a long-term observational study of inpatient mental healthcare in a large psychiatric hospital association in North Rhine-Westphalia, Germany, covering the second and third pandemic waves of autumn and winter 2020 followed up until June 2021. Analysis of the changes of inpatient and day patient mental healthcare utilization in an association of psychiatric hospitals during the COVID-19 pandemic from January 2020 until June 2021. We used the statistics database of the association of the nine psychiatric hospitals of the Rhineland Regional Council (Landschaftsverband Rheinland, LVR). We compared the case numbers of the pandemic period with previous years and analyzed changes in the diagnostic spectrum, rates of coercion and therapeutic outcomes. We also analyzed age, gender, diagnoses and coercive measures of patients tested positive for COVID-19 during inpatient psychiatric healthcare. Case rates were reduced during and after the COVID-19 pandemic episodes of 2020 and the following months of spring and summer 2021. Changes varied between diagnostic groups, and there were even increases of case numbers for acute psychotic disorders. Coercive measures increased during the pandemic, but therapeutic outcomes were maintained at the pre-pandemic level. Women and patients of higher ages were overrepresented among psychiatric inpatients with COVID-19. The COVID-19 pandemic led to over during reductions of inpatient psychiatric hospital admissions and changes of the diagnostic spectrum accompanied by increased rates of coercive measures. These effects may reflect an overall increased severity of mental disorders during the COVID-19 pandemic, deferrals of inpatient admissions or a lack of outpatient mental healthcare services utilization. To differentiate and quantitate these potential factors, further studies in the general population and in the different mental healthcare sectors are needed. In order to reduce the number of COVID-19 cases in psychiatric hospitals, vaccination of people of higher ages and with dementias seem to be the most needed strategy.

Sections du résumé

Background UNASSIGNED
During the first phase of the Coronavirus-19 disorder (COVID-19) pandemic in the spring of 2020, utilization of inpatient mental healthcare was significantly reduced. We now report on a long-term observational study of inpatient mental healthcare in a large psychiatric hospital association in North Rhine-Westphalia, Germany, covering the second and third pandemic waves of autumn and winter 2020 followed up until June 2021.
Objectives UNASSIGNED
Analysis of the changes of inpatient and day patient mental healthcare utilization in an association of psychiatric hospitals during the COVID-19 pandemic from January 2020 until June 2021.
Materials and methods UNASSIGNED
We used the statistics database of the association of the nine psychiatric hospitals of the Rhineland Regional Council (Landschaftsverband Rheinland, LVR). We compared the case numbers of the pandemic period with previous years and analyzed changes in the diagnostic spectrum, rates of coercion and therapeutic outcomes. We also analyzed age, gender, diagnoses and coercive measures of patients tested positive for COVID-19 during inpatient psychiatric healthcare.
Results UNASSIGNED
Case rates were reduced during and after the COVID-19 pandemic episodes of 2020 and the following months of spring and summer 2021. Changes varied between diagnostic groups, and there were even increases of case numbers for acute psychotic disorders. Coercive measures increased during the pandemic, but therapeutic outcomes were maintained at the pre-pandemic level. Women and patients of higher ages were overrepresented among psychiatric inpatients with COVID-19.
Conclusion UNASSIGNED
The COVID-19 pandemic led to over during reductions of inpatient psychiatric hospital admissions and changes of the diagnostic spectrum accompanied by increased rates of coercive measures. These effects may reflect an overall increased severity of mental disorders during the COVID-19 pandemic, deferrals of inpatient admissions or a lack of outpatient mental healthcare services utilization. To differentiate and quantitate these potential factors, further studies in the general population and in the different mental healthcare sectors are needed. In order to reduce the number of COVID-19 cases in psychiatric hospitals, vaccination of people of higher ages and with dementias seem to be the most needed strategy.

Identifiants

pubmed: 36620689
doi: 10.3389/fpsyt.2022.957951
pmc: PMC9814723
doi:

Types de publication

Journal Article

Langues

eng

Pagination

957951

Informations de copyright

Copyright © 2022 Zielasek, Lehmann, Vrinssen and Gouzoulis-Mayfrank.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Brain Behav Immun. 2020 Oct;89:531-542
pubmed: 32485289
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
J Psychiatr Res. 2020 Dec;131:244-254
pubmed: 33035957
Psychiatr Serv. 2021 Mar 1;72(3):242-246
pubmed: 33076794
World Psychiatry. 2020 Jun;19(2):130-131
pubmed: 32394549
BJPsych Open. 2020 Oct 12;6(6):e117
pubmed: 33040771
Transl Psychiatry. 2021 Jul 17;11(1):392
pubmed: 34282129
Front Public Health. 2021 Apr 30;9:593307
pubmed: 33996706
Psychol Med. 2021 Apr 20;:1-9
pubmed: 33875044
PLoS One. 2022 Aug 31;17(8):e0264046
pubmed: 36044407
Soc Psychiatry Psychiatr Epidemiol. 2021 Dec;56(12):2287-2297
pubmed: 34003305
Int J Psychiatry Clin Pract. 2021 Jun;25(2):135-139
pubmed: 33346685
BMC Psychiatry. 2021 Sep 24;21(1):465
pubmed: 34560856
Brain Behav. 2021 Aug;11(8):e2264
pubmed: 34213091
Nervenarzt. 2020 Nov;91(11):1047-1049
pubmed: 32710149
Am J Psychiatry. 2021 Mar 1;178(3):240-246
pubmed: 32972202
Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):377-379
pubmed: 32519205
J Psychiatr Res. 2021 Oct;142:140-143
pubmed: 34352559
World Psychiatry. 2020 Jun;19(2):129-130
pubmed: 32394569
J Psychiatr Ment Health Nurs. 2022 Apr;29(2):381-385
pubmed: 33704877
Psychiatr Q. 2021 Jun;92(2):621-631
pubmed: 32839923
Psychiatry Clin Neurosci. 2020 Oct;74(10):557-559
pubmed: 32609417
Front Psychiatry. 2022 May 26;13:894939
pubmed: 35693974
Soc Psychiatry Psychiatr Epidemiol. 2021 Aug;56(8):1469-1475
pubmed: 33866383
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110304
pubmed: 33737215
Front Psychiatry. 2020 Nov 26;11:585915
pubmed: 33324258
Fortschr Neurol Psychiatr. 2021 Sep;89(9):424-432
pubmed: 34126645
Eur Psychiatry. 2020 May 20;63(1):e45
pubmed: 32431255
World Psychiatry. 2020 Oct;19(3):406-407
pubmed: 32931089
Brain Sci. 2021 Oct 26;11(11):
pubmed: 34827412
Int J Environ Res Public Health. 2021 Jan 28;18(3):
pubmed: 33525740

Auteurs

Jürgen Zielasek (J)

LVR-Institute for Healthcare Research, Cologne, Germany.
Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Isabell Lehmann (I)

LVR-Institute for Healthcare Research, Cologne, Germany.

Jürgen Vrinssen (J)

LVR-Institute for Healthcare Research, Cologne, Germany.

Euphrosyne Gouzoulis-Mayfrank (E)

LVR-Institute for Healthcare Research, Cologne, Germany.
LVR Clinic Cologne, Cologne, Germany.

Classifications MeSH